In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Enliven Therapeutics Inc (NASDAQ: ELVN) was $16.52 for the day, up 4.42% from the previous closing price of $15.82. In other words, the price has increased by $4.42 from its previous closing price. On the day, 0.6 million shares were traded. ELVN stock price reached its highest trading level at $17.19 during the session, while it also had its lowest trading level at $14.47.
Ratios:
Our analysis of ELVN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 19.99 and its Current Ratio is at 19.99. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on December 13, 2024, initiated with a Buy rating and assigned the stock a target price of $42.
On September 09, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $37.
On June 11, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $32.Robert W. Baird initiated its Outperform rating on June 11, 2024, with a $32 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 07 ’25 when Patel Anish sold 6,667 shares for $18.04 per share. The transaction valued at 120,269 led to the insider holds 316,643 shares of the business.
Patel Anish bought 6,667 shares of ELVN for $124,606 on Apr 07 ’25. On Mar 27 ’25, another insider, Hohl Benjamin, who serves as the CHIEF FINANCIAL OFFICER of the company, sold 3,250 shares for $21.33 each. As a result, the insider received 69,321 and left with 23,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELVN now has a Market Capitalization of 809552704 and an Enterprise Value of 602452672.
Stock Price History:
The Beta on a monthly basis for ELVN is 1.12, which has changed by -0.30646515 over the last 52 weeks, in comparison to a change of 0.049593568 over the same period for the S&P500. Over the past 52 weeks, ELVN has reached a high of $30.03, while it has fallen to a 52-week low of $15.14. The 50-Day Moving Average of the stock is -20.41%, while the 200-Day Moving Average is calculated to be -29.27%.
Shares Statistics:
ELVN traded an average of 264.61K shares per day over the past three months and 438990 shares per day over the past ten days. A total of 48.94M shares are outstanding, with a floating share count of 31.69M. Insiders hold about 35.34% of the company’s shares, while institutions hold 72.81% stake in the company. Shares short for ELVN as of 1741910400 were 7335188 with a Short Ratio of 27.72, compared to 1739491200 on 7442501. Therefore, it implies a Short% of Shares Outstanding of 7335188 and a Short% of Float of 35.169998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
